Literature DB >> 9853055

[Fanconi disease: study of 43 cases in southern Tunisia].

M Frikha1, S Mseddi, M Elloumi, M Bouaziz, A Khanfir, J Mnif, A Saad, T Souissi.   

Abstract

BACKGROUND: To report the epidemiologic, clinical, biological features and course of Fanconi's anemia in southern Tunisia. PATIENTS AND METHODS: During a period of 12 years we observed 43 cases. For each patient, careful clinical, biological (hemogram, myelogram, bone marrow biopsy, hemoglobin electrophoresis, karyotype) and radiological (skeleton X-rays, abdominal echography and intravenous urography) examinations were performed. All the patients who were at a pancytopenia stage were given androgens. None had a bone marrow allograft.
RESULTS: There were 24 girls and 19 boys. The mean age at diagnosis was 10 years and 9 months. The familial character was present in 53% of the cases. The most frequent initial complaint was anemic syndrome (69%). In ten cases (24%), the diagnosis has been established during a familial investigation. Malformations were present in all cases (abnormal pigmentation: 86%; skeletal maturation retardation: 83%; facial dysmorphy: 76%; statural hypotrophy: 65%; bone abnormalities: 53%; renal malformations: 44%). Anemia was present in 88% of the cases, thrombocytopenia and neutropenia in all cases. Bone marrow was hypoplastic or aplastic in all cases on biopsies. Spontaneous chromosomal breaks were found in 79% of the studied cases. Fetal hemoglobin was increased in 80% of the studied cases with a mean level of 20.5%. Actuarial survival rate at 5 years was 48%, but long survival durations were rare (eight out of 43 patients). DISCUSSION: This disease, rare in the world, seems to be frequent in southern Tunisia. A normal karyotype (with classical techniques), found in five patients, could not discard the diagnosis; for this reason, the use of sensitizing agents should improve the sensitivity of the test. Besides, an increased level of fetal hemoglobin enabled us to suggest the diagnosis in some cases. Androgenotherapy increased the survival duration to more than 5 years in eight patients. However, bone marrow allograft remains the only possibility of cure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9853055     DOI: 10.1016/s0929-693x(98)81232-3

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  5 in total

1.  Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.

Authors:  Chiraz Bouchlaka; Sonia Abdelhak; Ahlem Amouri; Hela Ben Abid; Sondes Hadiji; Mounir Frikha; Tarek Ben Othman; Fethi Amri; Hammadi Ayadi; Mongia Hachicha; Ahmed Rebaï; Ali Saad; Koussay Dellagi
Journal:  J Hum Genet       Date:  2003-06-24       Impact factor: 3.172

2.  Correlation of thyroid and growth hormones to chromosomal instability in Egyptian Fanconi anemia patients.

Authors:  Mohammad Al-Haggar; Zakaria Al-Morsy; Sohier Yahia; Nehad Chalaby; Amany Ragab; Abeer Mesbah
Journal:  Indian J Pediatr       Date:  2008-08-21       Impact factor: 1.967

3.  [Fanconi anemia at the University Hospital (CHU) Hassan II of Fez: about 6 cases].

Authors:  Laila Bouguenouch; Imane Samri; Meryem Abbassi; Hasna Hamdaoui; Ihssane El Otmani; Hanane Sayel; Said Trhanint; Sara Benmiloud; Moncif Amrani; Sanae Bennis; Karim Ouldim; Mustapha Hida
Journal:  Pan Afr Med J       Date:  2017-12-04

4.  Spectrum of Genetic Diseases in Tunisia: Current Situation and Main Milestones Achieved.

Authors:  Nessrine Mezzi; Olfa Messaoud; Rahma Mkaouar; Nadia Zitouna; Safa Romdhane; Ghaith Abdessalem; Cherine Charfeddine; Faouzi Maazoul; Ines Ouerteni; Yosr Hamdi; Anissa Zaouak; Ridha Mrad; Sonia Abdelhak; Lilia Romdhane
Journal:  Genes (Basel)       Date:  2021-11-19       Impact factor: 4.096

5.  [Fanconi anemia: report of a new case].

Authors:  Anass Es-Seddiki; Anass Ayyad; Sahar Messouadi; Rim Amrani
Journal:  Pan Afr Med J       Date:  2015-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.